Votes: IN SB0015 | 2017 | Regular Session

Bill Title: Cannabidiol for the treatment of epilepsy. Defines "cannabidiol" and provides an affirmative defense to possession of cannabidiol if the person or the person's child has been diagnosed with certain medical conditions, the cannabidiol contains not more than 0.3% THC and at least 10% cannabidiol, and other specified conditions are met. Provides civil immunity for a health care provider if the patient who possesses the cannabidiol is a part of a clinical trial.

Spectrum: Moderate Partisan Bill (Republican 14-4)

Status: (Enrolled - Dead) 2017-04-10 - House advisors appointed: Lehe, Miller D, Schaibley, DeLaney and Klinker [SB0015 Detail]

Text: Latest bill text (Engrossed) [PDF]

Voting Records

ChamberVoteDateYeaNayNVAbsTotalResultSourceView
HouseHouse - Third reading2017-04-0695014100PassedLinkView
HouseHouse - Committee Vote2017-03-291000313PassedLinkView
SenateSenate - Third reading2017-02-1438120050PassedLinkView
SenateSenate - Committee Vote2017-02-0753008PassedLinkView


Social Comments on IN SB0015

feedback